5Y4-25562-57225
4 vaccinations
5 coded responses
32 check-ins
5 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 242 / VA
- Registered
- 2020-12-30
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-30
Registered in v-safe
-
2020-12-30
Dose 1 — Moderna
- 2020-12-30
- 2020-12-31
- 2021-01-01
- 2021-01-02
- 2021-01-03
- 2021-01-04
- 2021-01-06
-
2021-01-13
Survey response — day 14, dose 1MedDRA: Injection site erythema, Injection site pruritus — Feeling: GoodFree text: Today developed 2 cm area that is pruritic and very mildly erythematous at the injection site. Has improved over last 6 hours. Nothing prior to today. Not major today just interesting after this long t have anything appear nowMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-21
Survey response — day 21, dose 1MedDRA: Injection site erythema, Injection site induration, Injection site pruritus, Injection site warmth — Feeling: GoodFree text: Area of injection erythema indicated warm and pruritic I duration 10X6 cm lasted 2 days resolved now Occurred on day 13-15 post vaccineMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-27
-
2021-02-02
Dose 2 — Moderna
-
2021-02-03
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-02-04
- 2021-02-05
- 2021-02-06
- 2021-02-07
- 2021-02-08
- 2021-02-09
- 2021-02-16
- 2021-02-23
- 2021-03-02
- 2021-03-09
- 2021-03-16
- 2021-05-04
- 2021-08-03
-
2021-10-26
Dose 3 — Moderna
- 2022-02-02
-
2022-04-12
Dose 4 — Moderna
-
2022-04-27
Survey response — day 14, dose 4MedDRA: Fatigue, Nausea, Vertigo, Vomiting — Feeling: Good · Be unable to do your normal daily activitiesFree text: Unusual Fatigue on 4-13-22; beginning April 18 experienced vertigo nausea and vomiting for 3 days from April 18-21 2022. Resolved without treatment nor did I seek medical attentionMedDRA releases: 2024-11 · check-in free text available
- 2022-05-03
- 2022-05-10
- 2022-05-17
-
2022-05-24
Survey response — day 42, dose 4MedDRA: Nasal congestion, Pre-existing disease, Sneezing — Feeling: GoodFree text: Nasal congestion sneezing probably seasonal allergies.MedDRA releases: 2024-11 · check-in free text available
-
2022-07-12
Survey response — 3 months, dose 4MedDRA: Cough, Fatigue, Illness, Malaise, Oropharyngeal pain, SARS-CoV-2 test negative, Sinus congestion — Feeling: Fair · Be unable to do your normal daily activitiesFree text: 3-4 weeks of illnesss beginning with sore throat and malaise then sinus congestion for 3-6 days then cough for 3+ weeks with persisting fatigue throughout. Two antigen tests for Covid 19 negative early in presentation. Symptomatic treatmentMedDRA releases: 2024-11 · check-in free text available
- 2022-10-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-30 | Moderna | |
| 2 | 2021-02-02 | Moderna | |
| 3 | 2021-10-26 | Moderna | No |
| 4 | 2022-04-12 | Moderna | No |
Free text
Release 1 — day 14, dose 1
Symptoms: Today developed 2 cm area that is pruritic and very mildly erythematous at the injection site. Has improved over last 6 hours. Nothing prior to today. Not major today just interesting after this long t have anything appear now
Release 2 — day 21, dose 1
Symptoms: Area of injection erythema indicated warm and pruritic I duration 10X6 cm lasted 2 days resolved now Occurred on day 13-15 post vaccine
Release 11 — day 14, dose 4
Symptoms: Unusual Fatigue on 4-13-22; beginning April 18 experienced vertigo nausea and vomiting for 3 days from April 18-21 2022. Resolved without treatment nor did I seek medical attention
Release 11 — day 42, dose 4
Symptoms: Nasal congestion sneezing probably seasonal allergies.
Release 12 — 3 months, dose 4
Symptoms: 3-4 weeks of illnesss beginning with sore throat and malaise then sinus congestion for 3-6 days then cough for 3+ weeks with persisting fatigue throughout. Two antigen tests for Covid 19 negative early in presentation. Symptomatic treatment
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Illness | · | · | ✓ |
| SD | Injection site erythema | ✓ | ✓ | ✓ |
| SD | Injection site induration | ✓ | ✓ | ✓ |
| SD | Injection site pruritus | ✓ | ✓ | ✓ |
| SD | Injection site warmth | ✓ | ✓ | ✓ |
| SD | Malaise | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Sinus congestion | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
| SD | Vertigo | · | · | ✓ |
| SD | Vomiting | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release